Saccharomyces Boulardii for Diarrhea Management

Research suggests that Saccharomyces boulardii, alongside select Lactobacillus strains, may offer meaningful benefits for both treating and preventing infectious diarrhea in young children, with proposed mechanisms including direct action against gut pathogens and reinforcement of intestinal immune defenses. The available evidence comes from a 2018 narrative review that synthesized existing clinical and mechanistic literature, concluding that these probiotics show genuine utility, particularly for children under five. However, the review itself acknowledged that gaps in clinical knowledge have constrained routine adoption in medical practice, and the evidence base represented here is limited to a single review rather than a body of independent trials or meta-analyses. Studies indicate that further research identifying additional probiotic candidates could help broaden these potential benefits, especially in regions where childhood diarrhea carries a significant disease burden.